Sanj K Patel

CIK 1532218 · CHAIRMAN & CEO · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$49.39M

Companies

5

Total Filings

68

Lifetime Open-Market Net

-$71.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KNSA CHAIRMAN & CEO 951,794 $51.89 $49.39M -$30.28M 42 2026-06-02
SYRS Director $0.00 $0 3 2017-09-22
BCRX Director $8.70 $0 3 2017-05-25
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted President & CEO 0 -$41.19M 19 2015-06-23
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Director 452 $19.00 $8.6K $0 1 2014-07-21

Recent Filings · Page 4 of 7

68 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-09-07 KNSA Grant (A) $0 EDGAR
2021-03-23 KNSA Grant (A) $0 EDGAR
2021-03-18 KNSA Grant (A) $0 EDGAR
2021-02-10 KNSA Mixed −29,234 -$1.25M EDGAR
2020-10-14 KNSA Mixed −100,000 -$5.05M EDGAR
2020-09-14 KNSA Grant (A) $0 EDGAR
2020-03-17 KNSA Grant (A) $0 EDGAR
2020-03-10 KNSA Sell (S) −33,115 -$662.3K EDGAR
2019-09-19 KNSA Grant (A) $0 EDGAR
2019-03-06 KNSA Grant (A) $0 EDGAR
Showing 3140 of 68
Page 4 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.